James A. Jamison
7Patents
5h-index
12Co-inventors
60Inventor score
Filing activity: Mar 7, 1996 → Mar 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5652213A | Cyclic peptide antifungal agents | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6323176A | Cyclic peptide antifungal agents | Human Necessities | 19 | Expired |
| US5646111A | Cyclic peptide antifungal Agents | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5618787A | Cyclic peptide antifungal agents | Human Necessities | 12 | Expired |
| US6670324B2 | Cyclic peptide antifungal agents | Human Necessities | 8 | Expired |
| US7326731B2 | Muscarinic agonists | Emerging Cross-Sectional Technologies | 2 | Expired |
| US12227538B2 | Glucocorticoid receptor agonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.